ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.

Carcinoma, Hepatocellular / genetics Chromatin Assembly and Disassembly / genetics Gene Expression Regulation / genetics Humans Liver Neoplasms / genetics Nuclear Proteins / metabolism Transcription Factors / genetics
ARID2 SWI/SNF cancer chromatin hepatocellular carcinoma

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
23 09 2020
Historique:
received: 30 07 2020
revised: 03 09 2020
accepted: 16 09 2020
entrez: 26 9 2020
pubmed: 27 9 2020
medline: 14 5 2021
Statut: epublish

Résumé

Chromatin remodelers are found highly mutated in cancer including hepatocellular carcinoma. These mutations frequently occur in

Identifiants

DOI: 10.3390/cells9102152 PMID: 32977645 PMC: PMC7598172
pubmed: 32977645
pii: cells9102152
doi: 10.3390/cells9102152
pmc: PMC7598172
pii:
doi:

Substances chimiques

ARID2 protein, human 0
Nuclear Proteins 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2018 Feb 16;359(6377):770-775
pubmed: 29301958
Am J Med Genet A. 2019 May;179(5):808-812
pubmed: 30838730
Cell. 2002 Feb 22;108(4):475-87
pubmed: 11909519
J Hepatol. 2020 Feb;72(2):215-229
pubmed: 31954487
Science. 2018 Feb 16;359(6377):801-806
pubmed: 29301960
J Hematol Oncol. 2018 Feb 26;11(1):27
pubmed: 29482581
Cell. 2018 Nov 15;175(5):1272-1288.e20
pubmed: 30343899
Mol Cell Biol. 2002 Sep;22(18):6471-9
pubmed: 12192045
Nat Cell Biol. 2018 Dec;20(12):1410-1420
pubmed: 30397315
J Cell Sci. 2011 Feb 1;124(Pt 3):359-68
pubmed: 21224400
J Transl Med. 2014 Jul 15;12:196
pubmed: 25023649
J Biol Chem. 2017 May 19;292(20):8459-8471
pubmed: 28381560
Nucleic Acids Res. 1996 Mar 1;24(5):803-7
pubmed: 8600444
Hepatology. 2007 Jan;45(1):42-52
pubmed: 17187432
Nat Rev Clin Oncol. 2020 Jul;17(7):435-448
pubmed: 32303701
Nat Genet. 2017 Feb;49(2):282-288
pubmed: 27941795
Oncotarget. 2011 Nov;2(11):886-91
pubmed: 22095441
J Pathol. 2016 Feb;238(3):389-400
pubmed: 26356327
Nat Genet. 2012 May 06;44(6):694-8
pubmed: 22561517
Nucleic Acids Res. 2005 Jan 07;33(1):66-80
pubmed: 15640446
Nat Genet. 2011 Aug 07;43(9):828-9
pubmed: 21822264
Biomed Pharmacother. 2020 Feb;122:109696
pubmed: 31918270
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4770-4780
pubmed: 32071245
Nat Genet. 2017 Feb;49(2):213-222
pubmed: 27941796
BMC Cancer. 2017 Dec 01;17(1):805
pubmed: 29191172
Mol Med Rep. 2019 Oct;20(4):3140-3148
pubmed: 31432113
Biosci Rep. 2019 Apr 16;39(4):
pubmed: 30914452
Mol Cell. 2014 Sep 4;55(5):723-32
pubmed: 25066234
Sci Adv. 2015 Jun 12;1(5):e1500447
pubmed: 26601204
Front Cell Neurosci. 2019 Jul 31;13:352
pubmed: 31417368
Cell Biochem Biophys. 2014 Jun;69(2):341-6
pubmed: 24604208
Science. 2020 Feb 21;367(6480):875-881
pubmed: 32001526
Exp Cell Res. 2015 Aug 15;336(2):232-41
pubmed: 26169693
Mol Aspects Med. 2019 Dec;70:33-56
pubmed: 31558293
Hepatology. 2012 Nov;56(5):1631-40
pubmed: 22610915
Nat Genet. 2012 Oct;44(10):1117-21
pubmed: 22922871
J Mol Biol. 1984 Oct 5;178(4):853-68
pubmed: 6436497
Genes Dev. 2005 Jul 15;19(14):1662-7
pubmed: 15985610
Hum Genet. 2017 Mar;136(3):297-305
pubmed: 28124119
Nature. 1998 Jul 9;394(6689):203-6
pubmed: 9671307
Genomics. 2005 Aug;86(2):242-51
pubmed: 15922553
Oncotarget. 2016 Oct 11;7(41):67321-67332
pubmed: 27634902
Mol Cell. 2000 Nov;6(5):1049-58
pubmed: 11106744
Nat Genet. 2019 Apr;51(4):618-626
pubmed: 30858614
EBioMedicine. 2020 Mar;53:102659
pubmed: 32113157
Cell. 2002 Nov 1;111(3):381-92
pubmed: 12419248
Oncogene. 2002 Aug 8;21(34):5193-203
pubmed: 12149641
Nat Cell Biol. 2019 Feb;21(2):152-161
pubmed: 30602726
Cell. 2017 Sep 21;171(1):34-57
pubmed: 28938122
Genes Dev. 1995 Nov 15;9(22):2770-9
pubmed: 7590252
Mol Cell Biol. 2004 May;24(10):4476-86
pubmed: 15121865
Mol Cancer. 2012 Jul 02;11:44
pubmed: 22747855
Cell. 1987 Feb 27;48(4):567-77
pubmed: 3545494
Nat Genet. 2015 May;47(5):505-511
pubmed: 25822088
Cell. 2012 Jul 20;150(2):251-63
pubmed: 22817889
EMBO J. 2002 Apr 15;21(8):1978-86
pubmed: 11953317
Med Sci Monit Basic Res. 2019 Oct 24;25:218-228
pubmed: 31645540
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15635-15644
pubmed: 31300537
Gut. 2019 Jun;68(6):1065-1075
pubmed: 30108162
Int J Cancer. 2013 May 1;132(9):2217-21
pubmed: 23047306
J Biol Chem. 2012 Feb 10;287(7):5033-41
pubmed: 22184115
Epigenetics Chromatin. 2013 Aug 01;6(1):24
pubmed: 23916056
J Virol. 2008 Jun;82(11):5295-306
pubmed: 18367535
Nat Genet. 2012 May 27;44(7):760-4
pubmed: 22634756
Biochem Biophys Res Commun. 2006 Aug 4;346(3):794-801
pubmed: 16782067
J Hepatol. 2014 Jan;60(1):224-6
pubmed: 23994386
Genetics. 1984 Dec;108(4):845-58
pubmed: 6392017
Nat Cell Biol. 2002 Oct;4(10):774-81
pubmed: 12244326
J Exp Clin Cancer Res. 2016 Jun 16;35(1):93
pubmed: 27306418
Am J Transl Res. 2016 Dec 15;8(12):5286-5297
pubmed: 28078002
Int J Biol Sci. 2020 Jul 19;16(14):2628-2647
pubmed: 32792861
Nat Genet. 2013 Jun;45(6):592-601
pubmed: 23644491
Oncotarget. 2016 Jul 19;7(29):45863-45875
pubmed: 27351279
PLoS One. 2014 Oct 09;9(10):e109493
pubmed: 25299188
Nat Rev Dis Primers. 2016 Apr 14;2:16018
pubmed: 27158749
J Hepatol. 2017 May;66(5):942-951
pubmed: 28238438
Am J Transl Res. 2017 Jun 15;9(6):2956-2965
pubmed: 28670383
J Cancer. 2018 Oct 18;9(22):4187-4196
pubmed: 30519319
Cancer Sci. 2017 Apr;108(4):620-631
pubmed: 28132399

Auteurs

Robin Loesch (R)

INSERM, Centre de Recherche des Cordeliers (CRC), Sorbonne Université, Université de Paris, F-75006 Paris, France.
Equipe labellisée "Ligue Nationale Contre le Cancer", F-75013 Paris, France.

Linda Chenane (L)

INSERM, Centre de Recherche des Cordeliers (CRC), Sorbonne Université, Université de Paris, F-75006 Paris, France.
Equipe labellisée "Ligue Nationale Contre le Cancer", F-75013 Paris, France.

Sabine Colnot (S)

INSERM, Centre de Recherche des Cordeliers (CRC), Sorbonne Université, Université de Paris, F-75006 Paris, France.
Equipe labellisée "Ligue Nationale Contre le Cancer", F-75013 Paris, France.
ORCID: 0000-0002-3949-9107

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Carcinome hépatocellulaire › ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Assemblage et désassemblage de la chromatine › ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines nucléaires › ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.